The proposed Administrative Core under the direction of Dr. Ellner (PI) and Mr. David Hom (Director) will take overall responsibility of management (fiscal, regulatory, operational), coordinating (operational, logistics), and oversight of all TBRU activities. The Administrative Core will assist proposed sites with study development (biostatistics, protocol, operating procedures), implementation and performance monitoring. The Core will also communicate and work with NIH program staff to monitor study progress and achieve proposed milestones. Lastly, the Administrative Core will work to leverage expertise across other TBRU programs with collaborative projects proposed by TBRU investigators. The Core will also operate a Data Management Center (DMC) to coordinate approved protocol and unit-wide scientific activities in concert with scientific decisions of the TBRU. The DMC will oversee the collection, storage, quality control, and evaluation of all study data. It will provide support and coordination for the statistical and data processing functions for proposed studies at all sites - clinical, animal, and translational. A detailed Management Plan will outline general activities, leadership structure, typical work-flow, chain of responsibility, review/approval processes, review committees and management activities across the TBRU members. Dr. Ellner has overall responsibility for the scientific, administrative, and fiscal activities of the TBRU and will provide vertical integration by directly interacting with leadership at each site. He will be ultimately responsible for scientific conduct and management of the TBRU.
TB remains a global public health emergency compounded by increasing drug resistance. Better tools are needed to control TB. Discovery of new markers for the development of TB and adequacy of treatment would allow evidence-based determination of treatment options for prevention and cure. The Administrative Core/Data Management Center will provide coordination, management of the proposed TBRU.
|Koch, Anastasia S; Brites, Daniela; Stucki, David et al. (2017) The Influence of HIV on the Evolution of Mycobacterium tuberculosis. Mol Biol Evol 34:1654-1668|
|Tientcheu, Leopold D; Koch, Anastasia; Ndengane, Mthawelenga et al. (2017) Immunological consequences of strain variation within the Mycobacterium tuberculosis complex. Eur J Immunol 47:432-445|
|Saito, Kohta; Warrier, Thulasi; Somersan-Karakaya, Selin et al. (2017) Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations. Proc Natl Acad Sci U S A 114:E4832-E4840|
|Jones-López, Edward C; Acuña-Villaorduña, Carlos; Fregona, Geisa et al. (2017) Incident Mycobacterium tuberculosis infection in household contacts of infectious tuberculosis patients in Brazil. BMC Infect Dis 17:576|
|Esmail, Hanif; Wilkinson, Robert J (2017) Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy. Ann Am Thorac Soc 14:621-623|
|Geadas, Carolina; Stoszek, Sonia K; Sherman, David et al. (2017) Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international. Tuberculosis (Edinb) 102:55-67|
|Vilchèze, Catherine; Hartman, Travis; Weinrick, Brian et al. (2017) Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 114:4495-4500|
|Yang, Jason H; Bening, Sarah C; Collins, James J (2017) Antibiotic efficacy-context matters. Curr Opin Microbiol 39:73-80|
|Prosser, Gareth; Brandenburg, Julius; Reiling, Norbert et al. (2017) The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition. Microbes Infect 19:177-192|
|Collins, Lauren F; Geadas, Carolina; Ellner, Jerrold J (2016) Diagnosis of Latent Tuberculosis Infection: Too Soon to Pull the Plug on the Tuberculin Skin Test. Ann Intern Med 164:122-4|
Showing the most recent 10 out of 16 publications